NOVARTIS AG-SPONSORED ADR (NVS) Stock Price, Quote, News and Overview

What is the stock price of NOVARTIS AG-SPONSORED ADR today?

The current stock price of NVS is 110.54 USD. The price decreased by -0.29% in the last trading session.

What is the ticker symbol for NOVARTIS AG-SPONSORED ADR stock?

The exchange symbol of NOVARTIS AG-SPONSORED ADR is NVS and it is listed on the New York Stock Exchange, Inc. exchange.

On which exchange is NVS stock listed?

NVS stock is listed on the New York Stock Exchange, Inc. exchange.

What is the price forecast or stock price prediction for NOVARTIS AG-SPONSORED ADR stock?

31 analysts have analysed NVS and the average price target is 119.24 USD. This implies a price increase of 7.87% is expected in the next year compared to the current price of 110.54. Check the NOVARTIS AG-SPONSORED ADR stock analysts ratings, price target forecast and up-and down grades for more detailed information.

What is NOVARTIS AG-SPONSORED ADR worth?

NOVARTIS AG-SPONSORED ADR (NVS) has a market capitalization of 218.33B USD. This makes NVS a Mega Cap stock.

How many employees does NOVARTIS AG-SPONSORED ADR have?

NOVARTIS AG-SPONSORED ADR (NVS) currently has 75883 employees.

What are the support and resistance levels for NOVARTIS AG-SPONSORED ADR (NVS) stock?

NOVARTIS AG-SPONSORED ADR (NVS) has a support level at 109.57 and a resistance level at 112.87. Check the full technical report for a detailed analysis of NVS support and resistance levels.

Is NOVARTIS AG-SPONSORED ADR (NVS) expected to grow?

The Revenue of NOVARTIS AG-SPONSORED ADR (NVS) is expected to grow by 4.87% in the next year. Check the estimates tab for more information on the NVS EPS, Sales, EBIT and EBITDA future analyst estimates.

Should I buy NOVARTIS AG-SPONSORED ADR (NVS) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of NVS, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of NVS, evaluating the profitability, health, valuation and growth aspects
• NOVARTIS AG-SPONSORED ADR (NVS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• NOVARTIS AG-SPONSORED ADR (NVS) Sales and EPS estimates to see what analysts future expectations are.
• NOVARTIS AG-SPONSORED ADR (NVS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• NOVARTIS AG-SPONSORED ADR (NVS) Insider and Institutional Ownership to learn about the owners and their transactions.
• NOVARTIS AG-SPONSORED ADR (NVS) Stock Chart to make your own analysis
• NOVARTIS AG-SPONSORED ADR (NVS) Latest news and press-releases to stay up to date.

Does NOVARTIS AG-SPONSORED ADR (NVS) stock pay dividends?

NOVARTIS AG-SPONSORED ADR (NVS) has a dividend yield of 3.86%. The yearly dividend amount is currently 3.79. Check the full fundamental report for a detailed analysis of NVS dividend history, reliability and sustainability.

When does NOVARTIS AG-SPONSORED ADR (NVS) report earnings?

NOVARTIS AG-SPONSORED ADR (NVS) will report earnings on 2025-04-29, before the market open.

What is the Price/Earnings (PE) ratio of NOVARTIS AG-SPONSORED ADR (NVS)?

The PE ratio for NOVARTIS AG-SPONSORED ADR (NVS) is 13.92. This is based on the reported non-GAAP earnings per share of 7.94 and the current share price of 110.54 USD. Check the full fundamental report for a full analysis of the valuation metrics for NVS.

What is the Short Interest ratio of NOVARTIS AG-SPONSORED ADR (NVS) stock?

The outstanding short interest for NOVARTIS AG-SPONSORED ADR (NVS) is 0.3% of its float. Check the ownership tab for more information on the NVS short interest.

ChartMill assigns a fundamental rating of 7 / 10 to NVS. NVS gets an excellent profitability rating and is at the same time showing great financial health properties.

Over the last trailing twelve months NVS reported a non-GAAP Earnings per Share(EPS) of 7.94. The EPS increased by 13.19% compared to the year before.

ChartMill assigns a Buy % Consensus number of 68% to NVS. The Buy consensus is the average rating of analysts ratings from 31 analysts.

For the next year, analysts expect an EPS growth of 11.31% and a revenue growth 4.87% for NVS